As always, way more questions than answers or clarity.

However, if RVX can get this Covid chapter zooming forward in Canada and Brazil, and begin BoM2 concurrently, I will be thrilled.

I like the Covid theories, and even if Omicron is not as huge a problem as previous strains, having a dual action solution for future variant strains is a game changer. And I happen to be VERY optimistic about BoM2, given design basics after what we learned from BoM.

So, they can't get BoM2 going fast enough for me, while continuing to drive Covid into high gear toward EUA. One can only hope solid Covid results gets apabetalone commercialized quickly to market under EUA, and then great early midterm results from BoM2 follows for more approvals.

Don would be forgiven and hailed as a game changing innovator, and we would all be laughing "all the way to the bank" (giggling like 5th grade school girls) about this "journey" were those things to happen.